ELAB — Elevai Labs Cashflow Statement
0.000.00%
Last trade - 00:00- $9.44m
- $8.50m
- $1.71m
Annual cashflow statement for Elevai Labs, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -0.13 | -0.785 | -1.8 | -4.3 |
| Depreciation | ||||
| Non-Cash Items | 0 | 0.143 | 0.195 | 0.556 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | 0.003 | -0.022 | 0.012 | -0.823 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Prepaid Expenses | ||||
| Change in Accounts Payable | ||||
| Change in Payable / Accrued Expenses | ||||
| Change in Other Liabilities | ||||
| Cash from Operating Activities | -0.127 | -0.661 | -1.59 | -4.56 |
| Capital Expenditures | 0 | -0.032 | -0.036 | -0.011 |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | — | — | 0.004 | 0 |
| Sale of Fixed Assets | ||||
| Cash from Investing Activities | 0 | -0.032 | -0.032 | -0.011 |
| Financing Cash Flow Items | — | — | — | -0.762 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 0.139 | 1.09 | 2.36 | 6.74 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 0.011 | 0.399 | 0.743 | 2.17 |